Jane Street Group, LLC Biogen Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 178,166 shares of BIIB stock, worth $31 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

178,166

Previous 85,994 107.18%

Holding current value

$31 Million

Previous $18.5 Million 122.75%

% of portfolio

0.05%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $17.6 Million - $21.8 Million	92,172 Added 107.18%	178,166 $41.3 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $25.2 Million - $31.8 Million	-118,694 Reduced 57.99%	85,994 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $35.1 Million - $42.3 Million	157,834 Added 336.86%	204,688 $53 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $22.3 Million - $25.2 Million	-88,059 Reduced 65.27%	46,854 $12 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $23.4 Million - $27 Million	85,003 Added 170.31%	134,913 $38.4 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $40.5 Million - $46.1 Million	-157,671 Reduced 75.96%	49,910 $13.9 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $24.5 Million - $29.7 Million	-96,959 Reduced 31.84%	207,581 $57.5 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $22.4 Million - $30.8 Million	114,830 Added 60.53%	304,540 $81.3 Million
Q2 2022 Aug 16, 2022	BUY	$187.54 - $223.02 $1.17 Million - $1.39 Million	6,227 Added 3.39%	189,710 $38.7 Million
Q1 2022 May 17, 2022	BUY	$193.77 - $244.14 $4.46 Million - $5.61 Million	22,992 Added 14.33%	183,483 $38.6 Million
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $14.9 Million - $19.1 Million	66,321 Added 70.43%	160,491 $38.5 Million
Q3 2021 Nov 16, 2021	BUY	$282.99 - $369.05 $3.25 Million - $4.24 Million	11,484 Added 13.89%	94,170 $26.6 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $10.4 Million - $16.6 Million	-40,009 Reduced 32.61%	82,686 $28.6 Million
Q1 2021 May 18, 2021	SELL	$242.95 - $284.63 $29.7 Million - $34.8 Million	-122,116 Reduced 49.88%	122,695 $34.3 Million
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $30.5 Million - $45.9 Million	129,054 Added 111.49%	244,811 $59.9 Million
Q3 2020 Nov 17, 2020	SELL	$264.77 - $305.71 $11.5 Million - $13.3 Million	-43,590 Reduced 27.36%	115,757 $32.8 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $33.1 Million - $43.8 Million	127,915 Added 406.96%	159,347 $42.6 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $4.68 Million - $5.93 Million	-17,389 Reduced 35.62%	31,432 $9.94 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $4.55 Million - $6.28 Million	-20,660 Reduced 29.73%	48,821 $14.5 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $565,778 - $634,575	2,602 Added 3.89%	69,481 $16.2 Million
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $10.6 Million - $11.7 Million	-48,473 Reduced 42.02%	66,879 $15.6 Million
Q1 2019 May 16, 2019	BUY	$216.71 - $338.96 $21.9 Million - $34.3 Million	101,280 Added 719.73%	115,352 $27.3 Million
Q4 2018 Feb 15, 2019	SELL	$278.5 - $352.75 $9.33 Million - $11.8 Million	-33,485 Reduced 70.41%	14,072 $4.23 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $5.69 Million - $7.44 Million	19,380 Added 68.78%	47,557 $16.8 Million
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $4.68 Million - $5.58 Million	18,177 Added 181.77%	28,177 $8.18 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $3.61 Million - $5.11 Million	-13,877 Reduced 58.12%	10,000 $2.74 Million
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $136,899 - $153,338	-445 Reduced 1.83%	23,877 $7.61 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $6.84 Million - $8.02 Million	24,322	24,322 $7.62 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Biogen Inc. Transaction History